MedTrace Logo

Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson's Disease

NCT01016470 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-05-04

No results posted yet for this study

Summary

The purpose of the study is to evaluate whether Viusid/Alzer Nutritional supplements, could improve the progression disease, in patients with Parkinson's Disease (PD).

Conditions

Interventions

DIETARY_SUPPLEMENT

VIUSID/ALZER

VIUSID/ALZER, 3 per day, oral, one year

DIETARY_SUPPLEMENT

Placebo

Placebo Viusid and Placebo Alzer, 3 per day, oral, one year

Sponsors & Collaborators

  • Catalysis SL

    lead INDUSTRY

Principal Investigators

  • Jose Luis Guiroud, PhD · "Salvador Allende" Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • Cuba

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01016470 on ClinicalTrials.gov